# EDGAR Filing Document

**Accession Number:** 0001218180
**File Stem:** 0000899243-23-005502
**Filing Date:** 2023-2
**Character Count:** 20033
**Document Hash:** 512fbdb9042fae5e495ef346b0dac591
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000899243-23-005502.hdr.sgml**: 20230217

**ACCESSION NUMBER**: 0000899243-23-005502

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230215

**FILED AS OF DATE**: 20230217

**DATE AS OF CHANGE**: 20230217

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Artal Group S.A.
- **CENTRAL INDEX KEY:** 0001053906
- **STATE OF INCORPORATION:** N4

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36177
- **FILM NUMBER:** 23644193

**BUSINESS ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L-2661
- **BUSINESS PHONE:** (352) 22.42.59-1

**MAIL ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L-2661

**FORMER NAME:**
- **FORMER CONFORMED NAME:** ARTAL GROUP S A
- **DATE OF NAME CHANGE:** 19980128
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Artal International S.C.A.
- **CENTRAL INDEX KEY:** 0001218180

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36177
- **FILM NUMBER:** 23644195

**BUSINESS ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L-2661
- **BUSINESS PHONE:** 352224259-1

**MAIL ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L-2661

**FORMER NAME:**
- **FORMER CONFORMED NAME:** ARTAL INTERNATIONAL SCA
- **DATE OF NAME CHANGE:** 20110531

**FORMER NAME:**
- **FORMER CONFORMED NAME:** ARTAL INTERNATIONAL SA
- **DATE OF NAME CHANGE:** 20030210
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Invus Public Equities Advisors, LLC
- **CENTRAL INDEX KEY:** 0001340096

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36177
- **FILM NUMBER:** 23644189

**BUSINESS ADDRESS:**
- **STREET 1:** C/O THE INVUS GROUP, LLC
- **STREET 2:** 750 LEXINGTON AVENUE, 30TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** (212) 371-1717

**MAIL ADDRESS:**
- **STREET 1:** C/O THE INVUS GROUP, LLC
- **STREET 2:** 750 LEXINGTON AVENUE, 30TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Westend S.A.
- **CENTRAL INDEX KEY:** 0001283968
- **STATE OF INCORPORATION:** N4
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36177
- **FILM NUMBER:** 23644192

**BUSINESS ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L-2661
- **BUSINESS PHONE:** 3522242591

**MAIL ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L-2661

**FORMER NAME:**
- **FORMER CONFORMED NAME:** WESTEND S.A.
- **DATE OF NAME CHANGE:** 20120816

**FORMER NAME:**
- **FORMER CONFORMED NAME:** WESTEND SA
- **DATE OF NAME CHANGE:** 20040317
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wittouck Amaury
- **CENTRAL INDEX KEY:** 0001841311

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36177
- **FILM NUMBER:** 23644191

**MAIL ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L2661
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Invus Public Equities, L.P.
- **CENTRAL INDEX KEY:** 0001340097

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36177
- **FILM NUMBER:** 23644196

**BUSINESS ADDRESS:**
- **STREET 1:** C/O THE INVUS GROUP, LLC
- **STREET 2:** 750 LEXINGTON AVENUE, 30TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 212-317-7520

**MAIL ADDRESS:**
- **STREET 1:** C/O THE INVUS GROUP, LLC
- **STREET 2:** 750 LEXINGTON AVENUE, 30TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

**FORMER NAME:**
- **FORMER CONFORMED NAME:** Invus Public Equities, LP
- **DATE OF NAME CHANGE:** 20050928
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Stichting Administratiekantoor Westend
- **CENTRAL INDEX KEY:** 0001460840
- **STATE OF INCORPORATION:** XX

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36177
- **FILM NUMBER:** 23644190

**BUSINESS ADDRESS:**
- **STREET 1:** CLAUDE DEBUSSYLAAN, 46
- **CITY:** AMSTERDAM
- **STATE:** P7
- **ZIP:** 1082 MD
- **BUSINESS PHONE:** 352-224-2591

**MAIL ADDRESS:**
- **STREET 1:** CLAUDE DEBUSSYLAAN, 46
- **CITY:** AMSTERDAM
- **STATE:** P7
- **ZIP:** 1082 MD
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Artal International Management S.A.
- **CENTRAL INDEX KEY:** 0001522131
- **STATE OF INCORPORATION:** N4
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36177
- **FILM NUMBER:** 23644194

**BUSINESS ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L-2661
- **BUSINESS PHONE:** 352224259-1

**MAIL ADDRESS:**
- **STREET 1:** VALLEY PARK
- **STREET 2:** 44, RUE DE LA VALLEE
- **CITY:** LUXEMBOURG
- **STATE:** N4
- **ZIP:** L-2661
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** GLYCOMIMETICS INC
- **CENTRAL INDEX KEY:** 0001253689
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 9708 MEDICAL CENTER DRIVE
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850
- **BUSINESS PHONE:** 240-243-1201

**MAIL ADDRESS:**
- **STREET 1:** 9708 MEDICAL CENTER DRIVE
- **CITY:** ROCKVILLE
- **STATE:** MD
- **ZIP:** 20850

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Invus Public Equities, L.P.<br><sub>(Last) (First) (Middle)</sub><br>750 LEXINGTON AVENUE 30TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10022<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GLYCOMIMETICS INC [ GLYC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Artal International S.C.A.<br><sub>(Last) (First) (Middle)</sub><br>VALLEY PARK, 44,<br>RUE DE LA VALLEE<br><sub>(Street)</sub><br>LUXEMBOURG, N4 L-2661<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GLYCOMIMETICS INC [ GLYC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Artal International Management S.A.<br><sub>(Last) (First) (Middle)</sub><br>VALLEY PARK, 44,<br>RUE DE LA VALLEE<br><sub>(Street)</sub><br>LUXEMBOURG, N4 L-2661<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GLYCOMIMETICS INC [ GLYC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Artal Group S.A.<br><sub>(Last) (First) (Middle)</sub><br>VALLEY PARK, 44,<br>RUE DE LA VALLEE<br><sub>(Street)</sub><br>LUXEMBOURG, N4 L-2661<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GLYCOMIMETICS INC [ GLYC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Westend S.A.<br><sub>(Last) (First) (Middle)</sub><br>VALLEY PARK, 44,<br>RUE DE LA VALLEE<br><sub>(Street)</sub><br>LUXEMBOURG, N4 L-2661<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GLYCOMIMETICS INC [ GLYC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wittouck Amaury<br><sub>(Last) (First) (Middle)</sub><br>VALLEY PARK, 44,<br>RUE DE LA VALLEE<br><sub>(Street)</sub><br>LUXEMBOURG, N4 L-2661<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GLYCOMIMETICS INC [ GLYC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Stichting Administratiekantoor Westend<br><sub>(Last) (First) (Middle)</sub><br>CLAUDE DEBUSSYLAAN, 46<br><sub>(Street)</sub><br>AMSTERDAM, P7 1082 MD<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GLYCOMIMETICS INC [ GLYC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Invus Public Equities Advisors, LLC<br><sub>(Last) (First) (Middle)</sub><br>750 LEXINGTON AVENUE 30TH FLOOR<br><sub>(Street)</sub><br>NEW YORK, NY 10022<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [X] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>GLYCOMIMETICS INC [ GLYC ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-02-15 |  | P |  | 1000000 | A | 2.1558<sup>(3)</sup> | 7573798 | D<sup>(1)(2)</sup> |  |
| Common Stock | 2023-02-16 |  | P |  | 315266 | A | 1.6847<sup>(4)</sup> | 7889064 | D<sup>(1)(2)</sup> |  |
| Common Stock | 2023-02-17 |  | P |  | 200000 | A | 1.705<sup>(5)</sup> | 8089064 | D<sup>(1)(2)</sup> |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) The Common Stock is held directly by Invus Public Equities, L.P. The general partner of Invus Public Equities, L.P. is Invus Public Equities Advisors, LLC. The Geneva branch of Artal International S.C.A. is the managing member of Invus Public Equities Advisors, LLC. The managing partner of Artal International S.C.A. is Artal International Management S.A., which is a wholly owned subsidiary of Artal Group S.A. Westend S.A. is the parent company of Artal Group, S.A., and the majority stockholder of Westend S.A. is Stichting Administratiekantoor Westend ("Stichting").

(2) (Continued from Footnote 1) Mr. Amaury Wittouck is the sole member of the board of Stichting. Each of the Reporting Persons, other than Invus Public Equities L.P., disclaims beneficial ownership of the securities held by the other Reporting Persons, except to the extent of such reporting person's pecuniary interest therein, and, pursuant to Rule 16a-1(a)(4) under the Exchange Act, each of the reporting persons (other than to the extent it directly holds securities reported herein) states that the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.

(3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.75 to $2.50 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

(4) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.80 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

(5) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.77 per share, inclusive. The Reporting Persons undertake to provide to GlycoMimetics, Inc., any security holder of GlycoMimetics, Inc., or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

**Signature:** Invus Public Equities, L.P., By: Invus Public Equities Advisors, LLC, its General Partner, By: /s/ Raymond Debbane, President  
**Date:** 2023-02-17

**Signature:** Invus Public Equities Advisors, LLC, By: /s/ Raymond Debbane, President  
**Date:** 2023-02-17

**Signature:** Artal International S.C.A., By: Artal International Management S.A., its Managing Partner, By: /s/ Anne Goffard, Managing Director  
**Date:** 2023-02-17

**Signature:** Artal International Management S.A., By: /s/ Anne Goffard, Managing Director  
**Date:** 2023-02-17

**Signature:** Artal Group S.A., By: /s/ Anne Goffard, Authorized Person  
**Date:** 2023-02-17

**Signature:** Westend S.A., By: /s/ Anne Goffard, Managing Director  
**Date:** 2023-02-17

**Signature:** Stichting Administratiekantoor Westend, By: /s/ Amaury Wittouck, Sole Member of the Board  
**Date:** 2023-02-17

**Signature:** /s/ Amaury Wittouck  
**Date:** 2023-02-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**